# An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

> **NCT03977792** · PHASE2 · UNKNOWN · sponsor: **Laboratoire Boreaderme Inc.** · enrollment: 164 (estimated)

## Conditions studied

- Recurrent Herpes Labialis

## Interventions

- **DRUG:** BOR15001L7
- **DRUG:** Docosanol Cream 10%

## Key facts

- **NCT ID:** NCT03977792
- **Lead sponsor:** Laboratoire Boreaderme Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09
- **Primary completion:** 2021-07
- **Final completion:** 2022-07
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2020-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03977792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03977792, "An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03977792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*